Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK or trading as Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
Targocid 200mg powder for solution for injection/infusion or oral solution.
| Pharmaceutical Form |
|---|
|
Powder for solution for injection/infusion or oral solution. Powder for solution for injection/infusion or oral solution: spongy ivory coloured homogeneous mass. |
Each vial contains 200 mg teicoplanin equivalent to not less than 200,000 IU.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Teicoplanin |
Teicoplanin inhibits the growth of susceptible organisms by interfering with cell-wall biosynthesis at a site different from that affected by beta-lactams. Peptidoglycan synthesis is blocked by specific binding to D-alanyl-D-alanine residues. |
| List of Excipients |
|---|
|
Sodium chloride |
Primary packaging:
The freeze-dried medicinal product is packaged in:
Type I, colourless glass vial of useful volume of 10 mL for 200 mg closed with bromobutyl rubber stopper and plastic flip-off top aluminium yellow overseal.
Pack sizes:
Not all pack sizes may be marketed.
Aventis Pharma Limited, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
or trading as
Sanofi, 410 Thames Valley Park Drive, Reading, Berkshire, RG6 1PT, UK
PL 04425/0088
Date of first authorisation: 2 August 1989
Date of latest Renewal: 12 December 2017
| Drug | Countries | |
|---|---|---|
| TARGOCID | Austria, Brazil, Estonia, Spain, Finland, France, Croatia, Ireland, Japan, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
